Improving prescribing practice in psychiatry: The experience of the Prescribing Observatory for Mental Health (POMH-UK)

International Review of Psychiatry

Volumn 23, Issue 4, 2011, Pages 328-335

  Barnes, Thomas R E ^a   Paton, Carol ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL COLLEGE OF PSYCHIATRISTS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; NOOTROPIC AGENT;

BEHAVIOR CHANGE; BIPOLAR DISORDER; CLINICAL PRACTICE; DRUG MEGADOSE; HEALTH CARE ORGANIZATION; HUMAN; INFORMATION DISSEMINATION; MEDICAL AUDIT; MEDICAL PRACTICE; MEDICAL SERVICE; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; METABOLIC SYNDROME X; PATIENT MONITORING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TOTAL QUALITY MANAGEMENT;

ANTIPSYCHOTIC AGENTS; GREAT BRITAIN; HUMANS; MENTAL HEALTH; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS; PSYCHIATRY; QUALITY IMPROVEMENT;

EID: 80054958532     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2011.606541     Document Type: Review

References (18)

1. Baker, J.A., Lovell, K. & Harris, N. (2007). Mental health professionals' psychotropic pro re nata (p.r.n.) medication practices in acute inpatient mental health care: A qualitative study. General Hospital Psychiatry, 29, 163-168.
2. Barnes, T.R.E., Paton, C., Cavanagh, M.-R., Hancock, E. & Taylor, D.M., on behalf of the UK Prescribing Observatory for Mental Health (2007). A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin, 33, 1397-1401.
3. Barnes, T.R.E., Paton, C., Hancock, E., Cavanagh, M.-R., Taylor, D., Lelliott, P., on behalf of the UK Prescribing Observatory for Mental Health (2008). Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: A quality improvement programme. Acta Psychiatrica Scandinavica, 118, 26-33. (Pubitemid 351832021)
4. Barnes, T.R.E., Shingleton-Smith, A. & Paton, C. (2009). Antipsychotic long-acting injections: Prescribing practice in the UK. British Journal of Psychiatry, 195, S37-S42.
5. Collins, N., Barnes, T.R.E., Shingleton-Smith, A., Gerrett, D. & Paton, C. (2010). Standards of lithium monitoring in mental health trusts in the UK. BMC Psychiatry, 10, 80.
6. Gerrett, D., Lamont, T., Paton, C., Barnes, T.R.E. & Shah, A. (2010). Safety alerts: Prescribing and monitoring lithium therapy: Summary of a safety report from the National Patient Safety Agency. British Medical Journal, 341, c6258.
7. NICE (2002a). Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia. NICE Health Technology Appraisal Guidance Number 43. London: National Institute for Health and Clinical Excellence.
8. NICE (2002b). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care.Clinical Guideline 1. www.nice.org.uk (accessed 19 May 2011).
9. NICE (2006). The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. Clinical Guideline 38. London: National Institute for Health and Clinical Excellence.
10. Paton, C., Barnes, T.R.E., Cavanagh, M.R., Taylor, D. & Lelliott, P., on behalf of the POMH-UK project team (2008). High-dose and combination antipsychotic prescribing in acute adult wards in the UK: The challenges posed by p.r.n. prescribing. British Journal of Psychiatry, 192, 435-439. (Pubitemid 351809896)
11. Paton, C., Barnes, T.R.E., Shingleton-Smith, A., McAllister- Williams, R.H., Kirkbride, J., Jones, P.B. & McIntyre, S., on behalf of the POMH-UK project team (2010). Lithium in bipolar and other affective disorders: Prescribing practice in the UK. Journal of Psychopharmacology, 24, 1739-1746.
12. Paton, C., Flynn, A., Shingleton-Smith, A., McIntyre, S., Bhaumik, S., Rasmussen, J., ... Barnes, T.R.E. (2011). Nature and quality of antipsychotic prescribing practice in UK psychiatry of learning disability services. Journal of Intellectual Disability Research, 55, 665-674.
13. Perecherla, S., Paton, C., Shingleton-Smith, A. & Barnes, T.R.E. (2009). Variations in anti-dementia drug prescribing. Progress in Neurology and Psychiatry, 13, 30-33.
14. Pope, A., Adams, C., Paton, C., Weaver, T. & Barnes, T.R.E. (2010). Assessment of adverse effects in clinical studies of antipsychotic medication: Survey of methods used. British Journal of Psychiatry, 197, 67-72.
15. POMH-UK (2010). Topic 1e Supplementary Report: Prescribing of High-Dose and Combination Antipsychotics on Adult Acute and Intensive Care Wards. London: Prescribing Observatory for Mental Health, CRTU088 (data on file).
16. Royal College of Psychiatrists (2006). Consensus Statement on High Dose Antipsychotic Medication. Council Report CR138. London: Royal College of Psychiatrists.
17. Thompson, A., Sullivan, S.A., Barley, M., Strange, S.O., Moore, L., Rogers, P., ... Harrison, G. (2008). The DEBIT trial: An intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards-A cluster randomized controlled trial. Psychological Medicine, 38, 705-715. (Pubitemid 351483230)
18. Usher, L. & Luck, L. (2004). Psychotropic PRN: A model for best practice management of acute psychotic behavioural disturbance in inpatient psychiatric settings. International Journal of Mental Health Nursing, 13, 18-21.